PARABOLIC DRUGS LTD.

NSE : PARABDRUGSBSE : 533211ISIN CODE : INE618H01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE5.700 (0 %)
PREV CLOSE ( ) 5.70
OPEN PRICE ( ) 5.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21
TODAY'S LOW / HIGH ( )5.70 5.70
52 WK LOW / HIGH ( )5.7 5.7
NSE5.500 (0 %)
PREV CLOSE( ) 5.50
OPEN PRICE ( ) 5.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5.50 (24000)
VOLUME 123
TODAY'S LOW / HIGH( ) 5.50 5.50
52 WK LOW / HIGH ( )5.5 5.5
( in Million)
Select year
ParticularsMar2018Mar2017Mar2016Mar2015Mar2014
Profit Before Tax-557.89-1050.35-4812.69-2501.49-2220.81
Adjustment428.95644.531748.441722.101519.50
Changes In working Capital159.61438.133960.85744.92739.03
Cash Flow after changes in Working Capital30.6732.31896.60-34.4737.72
Cash Flow from Operating Activities30.6732.31896.60-34.47307.49
Cash Flow from Investing Activities8.635.0113.89-159.04-299.94
Cash Flow from Financing Activities-37.03-38.18-935.17164.85-78.81
Net Cash Inflow / Outflow2.27-0.86-24.68-28.66-71.26
Opening Cash & Cash Equivalents6.427.2831.9660.63131.90
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent8.696.427.2831.9760.64

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.